News
9h
Stocktwits on MSNEli Lilly’s Alzheimer’s Drug Gets US FDA Label Update For More Gradual Dosing After Study Shows Reduced Side EffectsEli Lilly and Company (LLY) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved a label ...
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...
Opinion: Orrick's Irena Royzman and Dana Sublett write that judges have done a good job in multiple decisions that protect ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results